Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Ostróda – page 9

327 clinical trials in Ostróda, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Ostróda at a glance
327
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

327 trials in Ostróda

Open in trial search

Study of Ruxolitinib and Chemotherapy Drug Combination for Children with Acute Lymphoblastic Leukemia and JAK/STAT Pathway Activation

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Asparaginase
  • Sponsor:Medical University Of Lodz

Study of Pembrolizumab and V940 for Treating Non-Small Cell Lung Cancer in Patients with Resectable Stage II to IIIB (N2) Not Achieving Complete Response

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

Psychotic disorder+1

Recruiting

Study on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer's-Related Psychosis

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Karuna Therapeutics Inc.

Study on Valacyclovir for Preventing and Treating Cytomegalovirus (CMV) in Pregnant Women

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Valaciclovir
  • Sponsor:Instytut Matki I Dziecka

Study Comparing MK-2870 and Pembrolizumab Combination to Pembrolizumab Alone for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Merck Sharp & Dohme LLC

Study on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Cyclophosphamide
  • Sponsor:Universitaetsklinikum Muenster AöR

Neoplasm+5

Recruiting

Study for Patients with Lung or Urinary Tract Cancer Continuing Treatment with Durvalumab, Infliximab, and Mycophenolate Mofetil

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:AstraZeneca AB

Study on Personalized Treatment for Acute Myeloid Leukemia Using Cladribine, Daunorubicin, Cytarabine, and Drug Combinations for Specific Patient Groups

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cladribine
  • Sponsor:Medical University Of Lodz

Study on the Safety and Effects of Divarasib with Pembrolizumab and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:F. Hoffmann-La Roche AG

Study of MK-1084 and Pembrolizumab for First-Line Treatment in Patients with Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation and High PD-L1 Levels

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:MK-1084
  • Sponsor:Merck Sharp & Dohme LLC

Study Comparing Nemtabrutinib, Ibrutinib, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Merck Sharp & Dohme LLC

Thalassaemia beta+2

Recruiting

Study of SP-420 for Patients with Transfusion-Dependent Alpha or Beta Thalassemia

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Petadeferitrin
  • Sponsor:Pharmacosmos A/S

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Ostróda

What the registry says about research in the country

01 Respiratory Diseases

Innovative research focusing on chronic obstructive pulmonary disease (COPD) and asthma management. Multiple trials are evaluating novel therapeutic approaches to reduce exacerbations and improve lung function in patients with moderate to severe conditions.

  • COPD Treatment Advancement
  • Severe Asthma Control
  • Respiratory Function Improvement

These studies aim to enhance the quality of life for patients with chronic respiratory conditions through targeted therapies.

02 Viral Infections

Current research explores treatments for respiratory syncytial virus (RSV) infections in high-risk adults. Studies are evaluating novel antiviral compounds to address acute respiratory infections and prevent complications.

  • RSV Treatment Development
  • Symptom Management
  • Prevention of Complications

The focus is on developing effective interventions for viral respiratory infections affecting vulnerable populations.

03 Musculoskeletal Conditions

Research initiatives examining treatments for knee osteoarthritis, with particular attention to mobility improvement and pain management. Real-world evidence studies are evaluating topical treatments' impact on patients' daily activities.

  • Pain Management Solutions
  • Physical Mobility Enhancement
  • Quality of Life Assessment

These trials aim to provide practical solutions for patients dealing with chronic joint conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.